UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39513 Outset Medical, Inc. (Exact name of Registrant as specified in its Charter) Delaware 20-0514392 Washington, D.C. 20549 (State or other jurisdiction of ...

Outset Medical, Inc. (NASDAQ:OM) Q3 2023 Earnings Call Transcript November 7, 2023 5:00 PM ET Company Participants Jim Mazzola - VP, IR Leslie Trigg - Chair & CEO Nabeel Ahmed - CFO Conference Call Participants Rick Wise - Stifel Josh Jennings - T.D. Cowen Kristen Stewart - CL King Suraj Kalia - Oppenheimer & Company Operator Good day, and thank you for standing by. Welcome to the Outset Medical Q3 2023 Earnings Conference Call. [Operator Instructions]. Please be advised that today's conference is being rec ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39513 Outset Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-0514392 (State or other jurisdi ...

0% Dropout during in-home period 99% ~10% Reported less cramping during treatment | --- | --- | |--------------------------------------------|-------| | | | | 61% | | | | | | Felt more relaxed during treatment | | | 48% | | | | | | Had fewer headaches after dialysis | | | 47% | | Commercial strategy Acute DRIVERS / BENEFITS New revenue stream Attractive contribution margin Discharge management solution Home | --- | --- | --- | --- | |------------------------------------|-------|-------|-------| | capitalize ...

Outset Medical, Inc. (NASDAQ:OM) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET Company Participants Jim Mazzola - Vice President, Investor Relations Leslie Trigg - Chair & Chief Executive Officer Nabeel Ahmed - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Rick Wise - Stifel Shagun Singh - RBC Capital Markets Suraj Kalia - Oppenheimer & Company Josh Jennings - TD Cowen Drew Ranieri - Morgan Stanley Operator Good day, and thank you for standing-by ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) Delaware 20-0514392 (State or other jurisdiction of incorporation or organization) 3052 Orchard Dr. San Jose, California 95134 (Address of principal executive offices) (Zip Code) For the quarterly period ended June 30, 2023 (I.R.S. Employer Identification No.) OR Registrant's telephone number, including area code: (669) 231-8200 ...

| --- | --- | --- | |-------|-------|-------| | | | | | | | | | | | | Forward-looking statements and non-GAAP information This presentation and the accompanying oral statements contain forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "expect," "plan," anticipate," "believe," "es ...

Outset Medical, Inc. (NASDAQ:OM) Q1 2023 Results Conference Call May 3, 2023 5:00 PM ET Company Participants Jim Mazzola - Head, IR Leslie Trigg - Chair and CEO Nabeel Ahmed - CFO Conference Call Participants Rick Wise - Stifel Travis Steed - BofA Securities Shagun Singh - RBC Capital Markets Suraj Kalia - Oppenheimer Josh Jennings - TD Cowen Drew Ranieri - Morgan Stanley Operator Good day, and thank you for standing by. Welcome to the Outset Medical's First Quarter 2023 Earnings Call. [Operator Instruction ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39513 Outset Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-0514392 (State or other jurisdictio ...

Outset Medical, Inc. (NASDAQ:OM) Q4 2022 Earnings Conference Call February 13, 2023 5:00 PM ET Company Representatives Leslie Trigg - Chair, Chief Executive Officer Nabeel Ahmed - Chief Financial Officer Jim Mazzola - Head of Investor Relations Conference Call Participants Travis Steed - Bank of America Rick Weiss - Stifel Shagun Singh - RBC Capital Markets Suraj Kalia - Oppenheimer Drew Ranieri - Morgan Stanley Operator Good day, and thank you for standing by. Welcome to the Outset Medical Q4 2022 Earnings Con ...